The primary endpoint was the change in affected limb
volume, from baseline, assessed via volumetric measurements
on the 10th treatment day and 3 months post-treatment
completion. Secondary endpoints included changes in (1)
clinical symptom assessment (pain, heaviness, and tension)
via the use of visual analogue scales a